NCT01414166 Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108) Status TERMINATED Phase PHASE3
NCT01409421 RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence Status COMPLETED Phase NA
NCT01409213 A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199) Status COMPLETED Phase N/A
NCT01407276 A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009) Status COMPLETED Phase PHASE1
NCT01405937 Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044) Status COMPLETED Phase PHASE3
NCT01405924 Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030) Status TERMINATED Phase PHASE2
NCT01405911 Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105) Status COMPLETED Phase PHASE2
NCT01405560 Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045) Status COMPLETED Phase PHASE3
NCT01405027 Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy Status COMPLETED Phase PHASE4
NCT01404013 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Status UNKNOWN Phase PHASE4
NCT01402583 Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C Status COMPLETED Phase N/A
NCT01396005 A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123) Status COMPLETED Phase PHASE1
NCT01394354 Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM) Status COMPLETED Phase PHASE1/PHASE2
NCT01392118 Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change Status UNKNOWN Phase N/A
NCT01391546 Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Participants Aged From 50 Years Old (V211-045) Status COMPLETED Phase PHASE3
NCT01390844 Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063) Status COMPLETED Phase PHASE3
NCT01390441 A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002) Status TERMINATED Phase PHASE1
NCT01390428 Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013) Status COMPLETED Phase PHASE1